Brief: SynAct Pharma Completes Directed Issues Of 49.2 MSEK

SynAct Pharma AB

27/03/2024 08:56

March 27 (Reuters) - SynAct Pharma AB  SYNACT.ST :
    * SAID ON TUESDAY BOARD OF DIRECTORS RESOLVED ON A DIRECTED
ISSUE
OF 5,399,999 SHARES
    * SUBSCRIPTION PRICE 8.60 SEK PER SHARE
    * BOARD ALSO TO CONSIDER A PROPOSAL FOR A DIRECTED ISSUE OF
236,742 SHARES AT SUBSCRIPTION PRICE OF 8.60 SEK PER SHARE TO
BOARD MEMBERS, AND A DIRECTED ISSUE OF 88,743 SHARES AT A
SUBSCRIPTION PRICE OF 8.60 SEK PER SHARE TO MANAGEMENT 
    * CO WILL RECEIVE ABOUT SEK 49.2 MLN BEFORE ISSUE COSTS FROM
THESE
DIRECTED ISSUES


        
 Source text for Workspace:  urn:newsml:reuters.com:*:nNDL3Bv0Pk
 Further company coverage:  SYNACT.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))